Acceleration Initiative – An Outcome Driven Approach
Our Acceleration Initiative projects are highly innovative, address a significant challenge in pediatric cancer drug development, and have a strong probably of clinical application — ready to reach patients within three years.
Acceleration Initiative – Active PROJECTS
Andrew Kung, MD, PhD
Pediatric Sarcoma
